Your provider will review your health history, current medications, and weight loss goals
Beginning July 1 and running through the end of 2027, a new pilot program will allow some Medicare Part D prescription plan members who want to shed excess pounds and maintain weight loss to get Wegovy injections and tablets, Foundayo tablets or the Zepbound KwikPen for a $50 monthly copay
Novel small molecule analogs for advancing apelin receptor antagonism with enhanced plasma and microsomal stability
On a molecular level, AOD-9604 is compact enough to achieve good solubility in aqueous diluents yet large enough to retain the structural motif needed for its adipocyte-targeting activity
Key Takeaways Two biotech companies, Akston Biosciences and OKAVA Pharmaceuticals, are running early trials of once-weekly injections and a six-month implant GLP-1 treatment to tackle feline obesity, with no approved Ozempic for pets on the market yet
Managing semaglutide side effects effectively The difference between a miserable semaglutide experience and a manageable one often comes down to proactive management rather than reactive coping
